- Home
- BAP vs GEHC Comparison
BAP vs GEHC Comparison
Compare BAP & GEHC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | BAP | GEHC |
|---|---|---|
| Founded | 1889 | 1892 |
| Country | Peru | United States |
| Employees | N/A | N/A |
| Industry | Major Banks | Computer Software: Prepackaged Software |
| Sector | Finance | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 26.4B | 27.7B |
| IPO Year | 1997 | 2022 |
Fundamental Metrics
Financial Performance| Metric | BAP | GEHC |
|---|---|---|
| Price | $328.97 | $63.15 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 5 | 13 |
| Target Price | ★ $309.60 | $88.38 |
| AVG Volume (30 Days) | 361.1K | ★ 5.1M |
| Earning Date | 05-14-2026 | 04-29-2026 |
| Dividend Yield | ★ 3.46% | 0.24% |
| EPS Growth | N/A | ★ 4.84 |
| EPS | N/A | ★ 0.85 |
| Revenue | N/A | ★ $20,625,000,000.00 |
| Revenue This Year | $23.26 | $7.12 |
| Revenue Next Year | $8.62 | $4.45 |
| P/E Ratio | ★ $12.91 | $72.22 |
| Revenue Growth | N/A | ★ 4.84 |
| 52 Week Low | $193.13 | $58.75 |
| 52 Week High | $380.20 | $89.77 |
Technical Indicators
Market Signals| Indicator | BAP | GEHC |
|---|---|---|
| Relative Strength Index (RSI) | 50.13 | 38.11 |
| Support Level | $316.70 | $58.75 |
| Resistance Level | $363.15 | $75.11 |
| Average True Range (ATR) | 9.39 | 1.93 |
| MACD | 0.15 | -0.48 |
| Stochastic Oscillator | 45.14 | 28.01 |
Price Performance
Historical ComparisonAbout BAP Credicorp Ltd.
Credicorp Ltd is a Peruvian financial services company. It operates in four business lines, including Universal Banking, Insurance and Pensions, Microfinance, and Investment Management & Advisory. Its subsidiaries include Banco de Credito del Peru, Prima AFP, and Credicorp Capital. Geographically, the company operates in Peru, Colombia, Bolivia, Chile, Panama, the USA, and Mexico; the majority of its revenue is generated from Peru.
About GEHC GE HealthCare Technologies Inc.
GE HealthCare Technologies is a leading medical technology firm with leading market share in imaging and ultrasound equipment. The company reports four major segments: imaging (45% of revenue), advanced visualization solutions (26%), patient care solutions (15%), and pharmaceutical diagnostics (14%). The company's sales are geographically diverse, with the United States, EMEA, China, and the rest of the world accounting for 46%, 26%, 11%, and 17%, respectively. We estimate approximately half of its revenue is recurring, which consists of servicing (about one-third of revenue), pharmaceutical diagnostics (about 10%-15%), and digital solutions (just over 5%).